Carcinoma, Endometrioid
-
Subject Areas on Research
- Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
- Bariatric surgery as a means to decrease mortality in women with type I endometrial cancer - An intriguing option in a population at risk for dying of complications of metabolic syndrome.
- Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
- Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
- Endometrioid carcinoma of the endometrium with sertoliform differentiation.
- Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
- Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.
- Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
- Genetic instability of microsatellites in endometrial carcinoma.
- Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
- Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types.
- MicroRNAs in endometrial cancers from black and white patients.
- Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
- Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
- Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.
- Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
- Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
- Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray.
- Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.
- Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation.
- Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.
- Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.
- Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
- The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
- The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
- Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.
-
Keywords of People
- Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology